David Solit

86PUBLICATIONS
722CO-AUTHORS
NanomedicineMolecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (86)

|Nov 03, 2026
Location, Location, Location: Membranous Nectin-4 as a Biomarker for Enfortumab Vedotin.

|Oct 25, 2026
SLC25A28 is a synthetic lethal vulnerability in nucleotide excision repair-deficient cancers.

|Oct 20, 2026
Mutational Signatures and Hypermutation Phenotypes Define Bladder Cancers Arising in Waterpipe and Cigarette Smokers.

|Oct 10, 2026
CDKPredict: a clinicogenomic model for risk-adapted therapeutic intervention in breast cancer.

|Oct 08, 2026
Universal Germline Genetic Testing after a Diagnosis of Cancer.

|Sep 10, 2026
Target Antigen Identification for Antibody Drug Conjugate Therapy in Biliary Tract Cancer.

Pageof 15

Frequent Collaborators

33 joint publications

Michael F Berger

20 joint publications

Nikolaus Schultz

19 joint publications

Hikmat Al-Ahmadie

17 joint publications

Gopakumar V Iyer